Abstract:ID 99907 Poster Board 509 Radiation poses a serious threat to active-duty military personnel, causing a multitude of health problems for those who are exposed, including the potential for radiation-induced cognitive decline. Recent studies have shown that metformin–an antidiabetic drug–could attenuate the cognitive decline following radiotherapy for brain tumors. Our study tested the hypothesis that metformin prophylaxis would attenuate the central nervous system (CNS) effects of a whole-body non-lethal radiation exposure dose more representative of an exposure military personnel might encounter. Female Long-Evans rats were injected with metformin (200 mg/kg per day) for 7 days prior to exposure to gamma radiation (2 Gy; 0.6 Gy/m) using the AFRRI high level cobalt facility. At 2 days following radiation exposure, the effects of metformin prophylaxis were assessed on serum chemistry, hematological endpoints, blood hormone levels, and markers of cell proliferation and neuroinflammation in different brain regions. In a separate group of rats, a behavioral battery was assessed from 7-30 days following radiation exposure, assessing recognition and spatial memory, and anxiety-like and depressive-like behaviors. Following behavioral testing, serum chemistry, hematological endpoints, and makers of cell proliferation and neuroinflammation in different brain regions were assessed. At the 2-day time point, 2 Gy gamma radiation significantly decreased white blood cells, lymphocytes, monocytes, and reticulocytes, with no effect of metformin. Metformin did prevent the radiation-induced decrease in uric acid at this time point. Further, metformin administration appears to have prevented the radiation-induced decrease in lactate, as well, but this effect did not achieve significance. At the 30-day time point, metformin administration significantly increased recovery of reticulocytes. We found a significantly decreased Glu/Gla osteocalcin ratio at 2 days following radiation in the metformin + radiation group compared to sham control. At 30 days following radiation exposure, there was a significant effect of radiation on the Glu/Gla osteocalcin ratio, with radiation exposure resulting in a significant decrease in this ratio compared to sham control rats. This suggests that the Glu/Gla osteocalcin ratio is potentially a biomarker of radiation exposure. Rats receiving metformin prophylaxis showed faster habituation in the open field test compared to all other groups. Taken together, metformin shows potential as prophylaxis for radiation-induced changes following a non-lethal dose of gamma radiation. Intramural funds (AFR-B2-12672) from the Armed Forces Radiobiology Research Institute.

A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway

Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization

Exploring the Potential of Metformin in Mitigating Radiation-induced Gastrointestinal and Hematopoietic System Injury in Rats After Whole-body X-ray Radiation: An Experimental Study

Metformin Protects Against Radiation-Induced Pneumonitis and Fibrosis and Attenuates Upregulation of Dual Oxidase Genes Expression

Metformin Alleviates Radiation-Induced Skin Fibrosis via the Downregulation of FOXO3

Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells

Metformin as a Potential Countermeasure for the Central Nervous System Effects of Radiation Exposure

Radioprotective effect of the anti-diabetic drug metformin

Enhancing the anticancer effect of metformin through nanoencapsulation: Apoptotic induction, inflammatory reduction, and suppression of cell migration in colorectal cancer cells

Anti-radiation effect of MRN-100: a hydro-ferrate fluid, in vivo

Metformin and adipose-derived stem cell combination therapy alleviates radiation-induced skin fibrosis in mice

Mitochondria-Targeted Nitronyl Nitroxide Radical Nanoparticles for Protection against Radiation-Induced Damage with Antioxidant Effects

Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy

Integrative proteomics and targeted transcriptomics analyses in cardiac endothelial cells unravel mechanisms of long-term radiation-induced vascular dysfunction

Protective effect of trimetazidine in radiation-induced cardiac fibrosis in mice

Metformin Inhibits-The Growth-Of Nasopharyngeal Carcinoma Cells and Sensitizes the Cells to Radiation Via Inhibition of the Dna Damage Repair Pathway

The potential treatment of N-acetylcysteine as an antioxidant in the radiation-induced heart disease

Combined Administration of Pravastatin and Metformin Attenuates Acute Radiation-Induced Intestinal Injury in Mouse and Minipig Models

Effects of Combination Treatments with Astaxanthin-Loaded Microparticles and Pentoxifylline on Intracellular ROS and Radiosensitivity of J774A.1 Macrophages

Metformin's cardioprotective role in isoprenaline-induced myocardial infarction: Unveiling insights into the AMPK, NF-κB, JAK2/STAT3 pathways, and cholinergic regulation

Metformin-loaded chitosan nanoparticles augment silver nanoparticle-induced radiosensitization in breast cancer cells during radiation therapy